FindTrial
Sign In

To see the effect of Homoeopathic drug Bacillinum 1M on Tinea Corporis and Tinea Cruris

Exploring the role of Bacillinum 1M in cases of Tinea corporis and Tinea cruris.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028740
Enrollment
60
Registered
2020-10-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: Bacillinum 1 M: Bacilinum 1 M will be given to the patients suffering from Tinea Corporis and Tinea Cruris. Dose will be 4 pills three times a day for 15 days,Patient follow ups will be

Sponsors

Dr D Y Patil Vidyapeeth Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients whose diagnosis of Tinea is confirmed by KOH mount

Exclusion criteria

Exclusion criteria: 1.Patients receiving topical and systemic antifungal treatment 2. Those patients with the immuno-suppressive disease or on immunosuppressive drugs. 3. Pregnant and lactating women 4.HbsAg and HIV patients

Design outcomes

Primary

MeasureTime frame
Improvement in of each clinical parameter : itching,erythema,pustules,scaling and size and spread of the lesion.At the end KOH mountfindings will be done and compared to the pre trial investigationTimepoint: At the start of the trial and at the end of the trial after 18 months—

Secondary

MeasureTime frame
KOH mount being negative at the end of trial of each participantTimepoint: At the end of study—

Countries

India

Contacts

Public ContactDr Vipul Gandhi

Dr D Y Patil Homoeopathic Medical College and Research Centre Pune

vipul.gandhi@dpu.edu.in9823090080

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026